The cover story of the latest issue of CardioSource WorldNews Interventions discusses the interventional highlights from ACC.16 and the Cardiovascular Research Technologies (CRT) annual meeting, where transcatheter aortic valve replacement (TAVR) took center stage. New editor-in-chief, Peter C. Block, MD, FACC, discusses  the key issues facing interventional cardiologists. In the Peripheral Matters column, members of the ACC’s Peripheral Vascular Disease Section Leadership Council explain the recommendations of a collation of organizations, including the ACC, to a Medicare panel on interventions related to peripheral artery disease. See the full issue, including the final results of IBIS-3 on the use of rosuvastatin in non-intervened vessel of a real-practice population and insights into the results of the EVOLVE II clinical trial at ACC.org/CSWNI.